Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period
[1] [2] This extended half-life provides some metabolic benefit during short interruptions but also means that side effects may persist for several weeks after discontinuation
Under these policies, patients must first try one or more lower-cost medications before the insurer will approve the prescribed treatment
Pochini L, Galluccio M, Scalise M, Console L, Pappacoda G, Indiveri C
There is also a misclassification problem specific to these drugs
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
